Angiogenesis, Metabolic Regulation, and Cancer Biology

The formation, function and remodeling of the vasculature is intimately linked to the metabolic needs of the tissues it serves - whether that tissue is an essential organ or a pathological abnormality such as a tumor. Tools to investigate the complexity of molecular, cellular, and metabolic interactions amongst different tissues in vivo have only recently become available; the fields of angiogenesis, cancer biology, and metabolism have accordingly made rapid and exciting progress. This interdisciplinary meeting will bring these three fields together in an effort to connect them while capitalizing on new technologies. Our speakers will present recent advances in our understanding of how molecular signaling, cellular dynamics, and metabolic regulation converge during normal development and remodeling and highlight how studying angiogenesis regulation, stromal plasticity, and endothelial microenvironment offer unprecedented opportunities for designing new therapeutic strategies.

+ show speakers and program
Kari Alitalo, Helsingin Yliopisto, Finland
Chi Van Dang, Abramson Cancer Center, University of Pennsylvania, USA
Peter Carmeliet (organizer), VIB and Katholieke Universiteit Leuven, Belgium
Gabriele Bergers, University of California, San Francisco, USA
Stefanie Dimmeler, Goethe-University Frankfurt am Main, Germany
Ralph DeBerardinis, University of Texas - Southwestern Medical Center at Dallas, USA
Michele De Palma, Institut Suisse de Recherche Experimentale sur le Cancer (ISREC), Switzerland
Napoleone Ferrara, Genentech, USA
Holger Gerhardt, Cancer Research UK London Research Institute, UK and VIB, Belgium
Douglas Hanahan, Institut Suisse de Recherche Experimentale sur le Cancer (ISREC), Switzerland
Adrian Harris, Weatherall Institute of Molecular Medicine, University of Oxford, UK
Timothy Hla, Weill Medical College, Cornell University, USA
Luisa Iruela-Arispe, Cell and Developmental Biology University of California, Los Angeles, USA
Joseph Loscalzo, Harvard Medical School and Brigham and Women's Hospital, Boston, USA
Salvador Moncada, University College London, UK and VIB, Belgium
Michael Potente, Goethe-University Frankfurt am Main, Germany
Gregg Semenza, Johns Hopkins University School of Medicine, Baltimore, USA
M. Celeste Simon, University of Pennsylvania, USA
Inder Verma, The Salk Institute for Biological Studies, La Jolla, USA
Karen Vousden, The Beatson Institute for Cncer Research, Glasgow, UK

6 Jul - 8 Jul 2012
meeting website